APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tissue and Organ Transplantation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tissue and Organ Transplantation Market Analysis and Forecast 2026-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchTissue and Organ Transplantation Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Tissue and Organ Transplantation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tissue and Organ Transplantation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tissue and Organ Transplantation Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Tissue and Organ Transplantation Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tissue and Organ Transplantation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Tissue and Organ Transplantation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tissue and Organ Transplantation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tissue and Organ Transplantation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tissue and Organ Transplantation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Tissue and Organ Transplantation include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Tissue and Organ Transplantation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tissue and Organ Transplantation, also provides the revenue of main regions and countries. Of the upcoming market potential for Tissue and Organ Transplantation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tissue and Organ Transplantation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tissue and Organ Transplantation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Tissue and Organ Transplantation revenue, projected growth trends, production technology, application and end-user industry.

Tissue and Organ Transplantation Segment by Company

Arthrex

Biolife Solutions

Discovery Life Sciences

Medtronic

Stryker Corporation

Teva Pharmaceuticals

Veloxis Pharmaceutical

Zimmer Biomet

Abbvie

Novartis

Tissue and Organ Transplantation Segment by Type

Preservation Solution

Immunosuppressive Drugs

Tissue Products

Tissue and Organ Transplantation Segment by Application

Hospital

Transplant Centers

Others

Tissue and Organ Transplantation Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Tissue and Organ Transplantation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Tissue and Organ Transplantation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tissue and Organ Transplantation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tissue and Organ Transplantation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Preservation Solution Major Player Table 3. Immunosuppressive Drugs Major Player Table 4. Tissue Products Major Player Table 5. Global Tissue and Organ Transplantation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Transplant Centers Major Player Table 8. Others Major Player Table 9. Tissue and Organ Transplantation Industry Trends Table 10. Tissue and Organ Transplantation Industry Drivers Table 11. Tissue and Organ Transplantation Industry Opportunities and Challenges Table 12. Tissue and Organ Transplantation Industry Restraints Table 13. Global Tissue and Organ Transplantation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Tissue and Organ Transplantation Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Tissue and Organ Transplantation Market Share by Region (2021-2026) Table 16. Global Tissue and Organ Transplantation Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Tissue and Organ Transplantation Market Share by Region (2027-2032) Table 18. Global Tissue and Organ Transplantation Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Tissue and Organ Transplantation Revenue Market Share by Players (2021-2026) Table 20. Global Tissue and Organ Transplantation Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Tissue and Organ Transplantation Key Players Headquarters & Area Served Table 22. Global Tissue and Organ Transplantation Players, Product Type & Application Table 23. Global Tissue and Organ Transplantation Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Tissue and Organ Transplantation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Tissue and Organ Transplantation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Tissue and Organ Transplantation Revenue Market Share by Type (2021-2026) Table 30. Global Tissue and Organ Transplantation Revenue Market Share by Type (2027-2032) Table 31. Global Tissue and Organ Transplantation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Tissue and Organ Transplantation Revenue Market Share by Application (2021-2026) Table 35. Global Tissue and Organ Transplantation Revenue Market Share by Application (2027-2032) Table 36. Arthrex Company Information Table 37. Arthrex Business Overview Table 38. Arthrex Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Arthrex Tissue and Organ Transplantation Product Portfolio Table 40. Arthrex Recent Development Table 41. Biolife Solutions Company Information Table 42. Biolife Solutions Business Overview Table 43. Biolife Solutions Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biolife Solutions Tissue and Organ Transplantation Product Portfolio Table 45. Biolife Solutions Recent Development Table 46. Discovery Life Sciences Company Information Table 47. Discovery Life Sciences Business Overview Table 48. Discovery Life Sciences Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio Table 50. Discovery Life Sciences Recent Development Table 51. Medtronic Company Information Table 52. Medtronic Business Overview Table 53. Medtronic Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Medtronic Tissue and Organ Transplantation Product Portfolio Table 55. Medtronic Recent Development Table 56. Stryker Corporation Company Information Table 57. Stryker Corporation Business Overview Table 58. Stryker Corporation Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Stryker Corporation Tissue and Organ Transplantation Product Portfolio Table 60. Stryker Corporation Recent Development Table 61. Teva Pharmaceuticals Company Information Table 62. Teva Pharmaceuticals Business Overview Table 63. Teva Pharmaceuticals Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio Table 65. Teva Pharmaceuticals Recent Development Table 66. Veloxis Pharmaceutical Company Information Table 67. Veloxis Pharmaceutical Business Overview Table 68. Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio Table 70. Veloxis Pharmaceutical Recent Development Table 71. Zimmer Biomet Company Information Table 72. Zimmer Biomet Business Overview Table 73. Zimmer Biomet Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Zimmer Biomet Tissue and Organ Transplantation Product Portfolio Table 75. Zimmer Biomet Recent Development Table 76. Abbvie Company Information Table 77. Abbvie Business Overview Table 78. Abbvie Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Abbvie Tissue and Organ Transplantation Product Portfolio Table 80. Abbvie Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Tissue and Organ Transplantation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Novartis Tissue and Organ Transplantation Product Portfolio Table 85. Novartis Recent Development Table 86. North America Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Tissue and Organ Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Tissue and Organ Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Tissue and Organ Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Tissue and Organ Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 100. China Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 101. China Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 102. China Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 103. China Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Tissue and Organ Transplantation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Tissue and Organ Transplantation Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Tissue and Organ Transplantation Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Tissue and Organ Transplantation Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Tissue and Organ Transplantation Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Tissue and Organ Transplantation Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Tissue and Organ Transplantation Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Tissue and Organ Transplantation Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Tissue and Organ Transplantation Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Tissue and Organ Transplantation Image Figure 2. Global Tissue and Organ Transplantation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tissue and Organ Transplantation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Preservation Solution Image Figure 5. Immunosuppressive Drugs Image Figure 6. Tissue Products Image Figure 7. Global Tissue and Organ Transplantation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Tissue and Organ Transplantation Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Transplant Centers Image Figure 11. Others Image Figure 12. Global Tissue and Organ Transplantation Market Size (US$ Million) & (2021-2032) Figure 13. Global Tissue and Organ Transplantation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Tissue and Organ Transplantation Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Tissue and Organ Transplantation Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Tissue and Organ Transplantation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Tissue and Organ Transplantation Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Tissue and Organ Transplantation Revenue Market Share by Type (2021-2032) Figure 20. Global Tissue and Organ Transplantation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Tissue and Organ Transplantation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Tissue and Organ Transplantation Revenue Market Share by Application (2021-2032) Figure 23. North America Tissue and Organ Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Tissue and Organ Transplantation Revenue Share by Type (2021-2032) Figure 25. North America Tissue and Organ Transplantation Revenue Share by Application (2021-2032) Figure 26. North America Tissue and Organ Transplantation Revenue Share by Country (2021-2032) Figure 27. United States Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Tissue and Organ Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Tissue and Organ Transplantation Revenue Share by Type (2021-2032) Figure 32. Europe Tissue and Organ Transplantation Revenue Share by Application (2021-2032) Figure 33. Europe Tissue and Organ Transplantation Revenue Share by Country (2021-2032) Figure 34. Germany Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Tissue and Organ Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Tissue and Organ Transplantation Revenue Share by Type (2021-2032) Figure 44. China Tissue and Organ Transplantation Revenue Share by Application (2021-2032) Figure 45. Asia Tissue and Organ Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Tissue and Organ Transplantation Revenue Share by Type (2021-2032) Figure 47. Asia Tissue and Organ Transplantation Revenue Share by Application (2021-2032) Figure 48. Asia Tissue and Organ Transplantation Revenue Share by Region (2021-2032) Figure 49. Japan Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Tissue and Organ Transplantation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Tissue and Organ Transplantation Revenue Share by Type (2021-2032) Figure 57. SAMEA Tissue and Organ Transplantation Revenue Share by Application (2021-2032) Figure 58. SAMEA Tissue and Organ Transplantation Revenue Share by Country (2021-2032) Figure 59. Brazil Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Tissue and Organ Transplantation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Preservation Solution
  • Immunosuppressive Drugs
  • Tissue Products
Applications
  • Hospital
  • Transplant Centers
  • Others
Companies covered
  • Arthrex
  • Biolife Solutions
  • Discovery Life Sciences
  • Medtronic
  • Stryker Corporation
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical
  • Zimmer Biomet
  • Abbvie
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tissue and Organ Transplantation Market by Type
  3. 1.2.1 Global Tissue and Organ Transplantation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Preservation Solution
  5. 1.2.3 Immunosuppressive Drugs
  6. 1.2.4 Tissue Products
  7. 1.3 Tissue and Organ Transplantation Market by Application
  8. 1.3.1 Global Tissue and Organ Transplantation Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Transplant Centers
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Tissue and Organ Transplantation Market Dynamics
  1. 2.1 Tissue and Organ Transplantation Industry Trends
  2. 2.2 Tissue and Organ Transplantation Industry Drivers
  3. 2.3 Tissue and Organ Transplantation Industry Opportunities and Challenges
  4. 2.4 Tissue and Organ Transplantation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Tissue and Organ Transplantation Market Perspective (2021-2032)
  2. 3.2 Global Tissue and Organ Transplantation Growth Trends by Region
  3. 3.2.1 Global Tissue and Organ Transplantation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tissue and Organ Transplantation Market Size by Region (2021-2026)
  5. 3.2.3 Global Tissue and Organ Transplantation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Tissue and Organ Transplantation Revenue by Players
  2. 4.1.1 Global Tissue and Organ Transplantation Revenue by Players (2021-2026)
  3. 4.1.2 Global Tissue and Organ Transplantation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Tissue and Organ Transplantation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tissue and Organ Transplantation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Tissue and Organ Transplantation Key Players Headquarters & Area Served
  7. 4.4 Global Tissue and Organ Transplantation Players, Product Type & Application
  8. 4.5 Global Tissue and Organ Transplantation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Tissue and Organ Transplantation Market CR5 and HHI
  11. 4.6.3 2025 Tissue and Organ Transplantation Tier 1, Tier 2, and Tier 3
5 Tissue and Organ Transplantation Market Size by Type
  1. 5.1 Global Tissue and Organ Transplantation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 5.3 Global Tissue and Organ Transplantation Revenue Market Share by Type (2021-2032)
6 Tissue and Organ Transplantation Market Size by Application
  1. 6.1 Global Tissue and Organ Transplantation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Tissue and Organ Transplantation Revenue by Application (2021-2032)
  3. 6.3 Global Tissue and Organ Transplantation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Arthrex
  2. 7.1.1 Arthrex Company Information
  3. 7.1.2 Arthrex Business Overview
  4. 7.1.3 Arthrex Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
  6. 7.1.5 Arthrex Recent Developments
  7. 7.2 Biolife Solutions
  8. 7.2.1 Biolife Solutions Company Information
  9. 7.2.2 Biolife Solutions Business Overview
  10. 7.2.3 Biolife Solutions Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
  12. 7.2.5 Biolife Solutions Recent Developments
  13. 7.3 Discovery Life Sciences
  14. 7.3.1 Discovery Life Sciences Company Information
  15. 7.3.2 Discovery Life Sciences Business Overview
  16. 7.3.3 Discovery Life Sciences Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
  18. 7.3.5 Discovery Life Sciences Recent Developments
  19. 7.4 Medtronic
  20. 7.4.1 Medtronic Company Information
  21. 7.4.2 Medtronic Business Overview
  22. 7.4.3 Medtronic Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
  24. 7.4.5 Medtronic Recent Developments
  25. 7.5 Stryker Corporation
  26. 7.5.1 Stryker Corporation Company Information
  27. 7.5.2 Stryker Corporation Business Overview
  28. 7.5.3 Stryker Corporation Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
  30. 7.5.5 Stryker Corporation Recent Developments
  31. 7.6 Teva Pharmaceuticals
  32. 7.6.1 Teva Pharmaceuticals Company Information
  33. 7.6.2 Teva Pharmaceuticals Business Overview
  34. 7.6.3 Teva Pharmaceuticals Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
  36. 7.6.5 Teva Pharmaceuticals Recent Developments
  37. 7.7 Veloxis Pharmaceutical
  38. 7.7.1 Veloxis Pharmaceutical Company Information
  39. 7.7.2 Veloxis Pharmaceutical Business Overview
  40. 7.7.3 Veloxis Pharmaceutical Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
  42. 7.7.5 Veloxis Pharmaceutical Recent Developments
  43. 7.8 Zimmer Biomet
  44. 7.8.1 Zimmer Biomet Company Information
  45. 7.8.2 Zimmer Biomet Business Overview
  46. 7.8.3 Zimmer Biomet Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
  48. 7.8.5 Zimmer Biomet Recent Developments
  49. 7.9 Abbvie
  50. 7.9.1 Abbvie Company Information
  51. 7.9.2 Abbvie Business Overview
  52. 7.9.3 Abbvie Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
  54. 7.9.5 Abbvie Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Tissue and Organ Transplantation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
  60. 7.10.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Tissue and Organ Transplantation Revenue (2021-2032)
  2. 8.2 North America Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 8.2.1 North America Tissue and Organ Transplantation Revenue by Type (2021-2026)
  4. 8.2.2 North America Tissue and Organ Transplantation Revenue by Type (2027-2032)
  5. 8.3 North America Tissue and Organ Transplantation Revenue Share by Type (2021-2032)
  6. 8.4 North America Tissue and Organ Transplantation Revenue by Application (2021-2032)
  7. 8.4.1 North America Tissue and Organ Transplantation Revenue by Application (2021-2026)
  8. 8.4.2 North America Tissue and Organ Transplantation Revenue by Application (2027-2032)
  9. 8.5 North America Tissue and Organ Transplantation Revenue Share by Application (2021-2032)
  10. 8.6 North America Tissue and Organ Transplantation Revenue by Country
  11. 8.6.1 North America Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Tissue and Organ Transplantation Revenue by Country (2021-2026)
  13. 8.6.3 North America Tissue and Organ Transplantation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Tissue and Organ Transplantation Revenue (2021-2032)
  2. 9.2 Europe Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Tissue and Organ Transplantation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Tissue and Organ Transplantation Revenue by Type (2027-2032)
  5. 9.3 Europe Tissue and Organ Transplantation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Tissue and Organ Transplantation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Tissue and Organ Transplantation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Tissue and Organ Transplantation Revenue by Application (2027-2032)
  9. 9.5 Europe Tissue and Organ Transplantation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Tissue and Organ Transplantation Revenue by Country
  11. 9.6.1 Europe Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Tissue and Organ Transplantation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Tissue and Organ Transplantation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Tissue and Organ Transplantation Revenue (2021-2032)
  2. 10.2 China Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 10.2.1 China Tissue and Organ Transplantation Revenue by Type (2021-2026)
  4. 10.2.2 China Tissue and Organ Transplantation Revenue by Type (2027-2032)
  5. 10.3 China Tissue and Organ Transplantation Revenue Share by Type (2021-2032)
  6. 10.4 China Tissue and Organ Transplantation Revenue by Application (2021-2032)
  7. 10.4.1 China Tissue and Organ Transplantation Revenue by Application (2021-2026)
  8. 10.4.2 China Tissue and Organ Transplantation Revenue by Application (2027-2032)
  9. 10.5 China Tissue and Organ Transplantation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tissue and Organ Transplantation Revenue (2021-2032)
  2. 11.2 Asia Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Tissue and Organ Transplantation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Tissue and Organ Transplantation Revenue by Type (2027-2032)
  5. 11.3 Asia Tissue and Organ Transplantation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Tissue and Organ Transplantation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Tissue and Organ Transplantation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Tissue and Organ Transplantation Revenue by Application (2027-2032)
  9. 11.5 Asia Tissue and Organ Transplantation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Tissue and Organ Transplantation Revenue by Country
  11. 11.6.1 Asia Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Tissue and Organ Transplantation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Tissue and Organ Transplantation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tissue and Organ Transplantation Revenue (2021-2032)
  2. 12.2 SAMEA Tissue and Organ Transplantation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Tissue and Organ Transplantation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Tissue and Organ Transplantation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Tissue and Organ Transplantation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Tissue and Organ Transplantation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Tissue and Organ Transplantation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Tissue and Organ Transplantation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Tissue and Organ Transplantation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Tissue and Organ Transplantation Revenue by Country
  11. 12.6.1 SAMEA Tissue and Organ Transplantation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Tissue and Organ Transplantation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Tissue and Organ Transplantation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst